Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Sep 05, 2011 12:18 PM

Start: Dec 08, 2011 05:15 PM

[image reference is broken]

Speakers: Nicolas Hantzsch, Director, Groupon UK & Ireland
Each year, UCL's Department of Management Science and Innovation and UCL Advances organises a series of guest lectures from leading entrepreneurs and investors.

These will be held every Thursday evening (during term time) starting at 17:15. The venue is lecture theatre Roberts G06, Engineering Front Building, Malet Place on the main UCL campus. The event is open to all staff and students from UCL and the London Business School. No booking is required. 

Find out more >>